An investigation of the von Willebrand factor genotype in UK patients diagnosed to have type I von Willebrand disease

Thrombosis and Haemostasis

Volumn 96, Issue 5, 2006, Pages 630-641

  Cumming, Anthony ^a   Grundy, Pamela ^a   Keeney, Stephen ^a   Lester, William ^b   Enayat, Said ^b   Guilliatt, Andrea ^b   Bowen, Derrick ^c   Pasi, John ^d   Keeling, David ^e   Hill, Frank ^b   Bolton Maggs, Paula H B ^a   Hay, Charles ^a   Collins, Peter ^c  

^a MANCHESTER ROYAL INFIRMARY   (United Kingdom)

^b BIRMINGHAM CHILDREN S HOSPITAL   (United Kingdom)

^c CARDIFF UNIVERSITY   (United Kingdom)

^d ROYAL LONDON HOSPITAL   (United Kingdom)

^e CHURCHILL HOSPITAL   (United Kingdom)

Author keywords

Inherited bleeding disorders; Molecular pathogenesis; Type I VWD; VWF gene mutations

Indexed keywords

GENOMIC DNA; VON WILLEBRAND FACTOR;

ARTICLE; CONTROLLED STUDY; DIAGNOSTIC VALUE; DNA SEQUENCE; EXON; FAMILY; FEMALE; GENE DELETION; GENE MUTATION; GENE SEGREGATION; GENETIC LINKAGE; GENETIC POLYMORPHISM; GENETIC SCREENING; GENOTYPE; HAPLOTYPE; HUMAN; INTRON; MAJOR CLINICAL STUDY; MALE; PATHOGENESIS; PENETRANCE; PHENOTYPE; PRIORITY JOURNAL; PROMOTER REGION; UNITED KINGDOM; VON WILLEBRAND DISEASE;

DNA MUTATIONAL ANALYSIS; FAMILY HEALTH; FEMALE; GENOTYPE; GREAT BRITAIN; HAPLOTYPES; HUMANS; LINKAGE (GENETICS); MALE; MUTATION; PEDIGREE; PENETRANCE; POLYMORPHISM, GENETIC; VON WILLEBRAND DISEASE; VON WILLEBRAND FACTOR;

EID: 33751219230     PISSN: 03406245     EISSN: None     Source Type: Journal    
DOI: 10.1160/TH06-07-0383     Document Type: Article

References (44)

1. Rodeghiero F. von Willebrand disease: still an intriguing disorder in the era of molecular medicine. Haemophilia 2002; 8: 292-300.
2. Sadler JE. A revised classification of von Willebrand disease. For the Subcommittee on von Willebrand factor of the Scientific and Standardization Committee of the International Society on Thrombosis and Haemostasis. Thromb Haemost 1994; 71: 520-5.
3. Rodeghiero F, Castaman G, Dini E. Epidemiological investigation of the prevalence of von Willebrand's disease. Blood 1997; 69: 454-9.
4. Werner EJ, Broxson EH, Tucker EL, et al. Prevalence of von Willebrand disease in children: A multiethnic study. J Pediatr 1993; 123: 893-8.
5. Nichols WC, Ginsburg D. Reviews in molecular medicine: von Willebrand disease. Medicine 1997; 76: 1-20.
6. Miller CH, Graham JB, Goldin LR, et al. Genetics of classic von Willebrand's disease. I. Phenotypic variation within families. Blood 1979; 54: 117-45.
7. Castaman G, Eikenboom JCJ, Bertina RM, et al. Inconsistency of association between type 1 von Willebrand disease phenotype and genotype in families identified in an epidemiological investigation. Thromb Haemost 1999; 82: 1065-70.
8. Casana P, Martinez F, Haya S, et al. Significant linkage and non-linkage of type 1 von Willebrand disease to the von Willebrand factor gene. Br J Haematol 2001; 115: 692-700.
9. Lanke E, Johansson AM, Hallden C, et al. Genetic analysis of 31 Swedish type 1 von Willebrand disease families reveals incomplete linkage to the von Willebrand factor gene and a high frequency of a certain disease haplotype. J Thromb Haemost 2005; 3: 2656-63.
10. Eikenboom J, van Marion V, Putter H, et al. Linkage analysis in families diagnosed with type 1 von Willebrand disease in the European study, molecular and clinical markers for the diagnosis and management of type 1 VWD. J Thromb Haemost 2006; 4: 774-82.
11. James PD, Paterson AD, Notley C, et al. Genetic linkage and association analysis in type 1 von Willebrand disease: results from the Canadian Type 1 VWD Study. J Thromb Haemost 2006; 4: 783-92.
12. Sadler JE, Rodeghiero F, on behalf of the ISTHSSC Subcommittee on von Willebrand Factor. Provisional criteria for the diagnosis of VWD type 1. J Thromb Haemost 2005; 3: 775-7.
13. Sadler JE. Von Willebrand disease type 1: a diagnosis in search of a disease. Blood 2003; 101: 2089-93.
14. Sadler JE. Slippery criteria for von Willebrand disease type 1. J Thromb Haemost 2004; 2: 1720-3.
15. Levy G, Ginsburg D. Getting at the variable expressivity of von Willebrand disease. Thromb Haemost 2001; 86: 144-8.
16. De Lange M, de Geus EJ, Kluft C, et al. Genetic influences on fibrinogen, tissue plasminogen activator-antigen and von Willebrand factor in males and females. Thromb Haemost 2006; 95: 414-9.
17. Orstavik KH, Magnus P, Reisner H, et al. Factor VIII and factor IX in a twin population. Evidence for a major effect of ABO locus on factor VIII level. Am J Hum Genet 1985; 37: 89-101.
18. Gill JC, Endres-Brooks J, Bauer PJ, et al. The effect of ABO blood group on the diagnosis of von Willebrand disease. Blood 1987; 69: 1691-5.
19. Keeney S, Cumming AM. The molecular biology of von Willebrand disease. Clin Lab Haem 2001; 23: 209-30.
20. Laffan M, Brown SA, Collins PW, et al. The diagnosis of von Willebrand disease: a guideline from the UK Haemophilia Centre Doctors' Organisation. Haemophilia 2004; 10: 199-217.
21. Federici AB, Canciani MT, Forza I, et al. Ristocetin cofactor and collagen binding activities normalized to antigen levels for a rapid diagnosis of type 2 von Willebrand disease. Single center comparison of four different assays. Thromb Haemost 2000; 84: 1127-8.
22. Enayat MS, Hill FGH. Analysis of the complexity of the multimeric structure of factor VIII-related antigen/von Willebrand protein using a modified electrophoretic technique. J Clin Pathol 1983; 36: 915-9.
23. Mancuso DJ, Tuley EA, Westfield LA, et al. Structure of the gene for human von Willebrand factor. J Biol Chem 1989; 264: 19514-27.
24. Strauss EC, Kobori JA, Siu G, et al. Specific-primer-directed DNA sequencing. Anal Biochem 1986; 154: 353-60.
25. Bonfield JK, Rada C, Staden R. Automated detection of point mutations using fluorescent sequence trace subtraction. Nucleic Acids Res 1998; 26: 3404-9.
26. Hilbert L, Gaucher C, Mazurier C. Identification of two mutations (Arg611Cys and Arg611His) in the A1 loop of von Willebrand factor (vWF) responsible for type 2 von Willebrand disease with decreased platelet-dependent function of vWF. Blood 1995; 86: 1010-8.
27. 611→His) in type I "platelet discordant" von Willebrand's disease with desmopressin-induced thrombocytopenia. Br J Haematol 1995; 89: 656-8.
28. Castaman G, Rodeghiero F, Mannucci PM. The elusive pathogenesis of von Willebrand disease Vicenza. Blood 2002; 99: 4243-4.
29. Castaman G, Missiaglia E, Federici AB, et al. An additional unique candidate mutation (G2470A; M740I) in the original families with von Willebrand disease type 2M Vicenza and the G3864A (R1205H) mutation. Thromb Haemost 2000; 84: 350-1.
30. Schneppenheim R, Federici AB, Budde U, et al. Von Willebrand disease type 2M "Vicenza" in Italian and German patients: identification of the first candidate mutation (G3864A; R1205H) in 8 families. Thromb Haemost 2000; 82: 136-40.
31. Baronciani L, Cozzi G, Canciani MT, et al. Molecular defects in type 3 von Willebrand disease: updated results from 40 multiethnic patients. Blood Cells Mol Dis 2003; 30: 264-70.
32. Bowen DJ, Collins PW, Lester W, et al. The prevalence of the cysteine1584 variant of von Willebrand factor is increased in type 1 von Willebrand disease: cosegregation with increased susceptibility to ADAMTS13 proteolysis but not clinical phenotype. Br J Haematol 2005; 128: 830-6.
33. Bowen DJ, Collins PW. An amino acid polymorphism in von Willebrand factor correlates with increased susceptibility to proteolysis by ADAMTS13. Blood 2004; 103: 941-7.
34. Bowen DJ. An influence of ABO blood group on the rate of proteolysis of von Willebrand factor by ADAMTS13. J Thromb Haemost 2003; 1: 3 3-40.
35. O'Brien LA, James PD, Othman M, et al. Founder von Willebrand factor haplotype associated with type 1 von Willebrand disease. Blood 2003; 102: 549-57.
36. Hilbert L, Jorieux S, Proulle V, et al. Two novel mutations, Q1053H and C1060R, located in the D3 domain of von Willebrand factor, are responsible for decreased FVIII-binding capacity. Br J Haematol 2003; 120: 627-32.
37. Berber E, James PD, Leggo J, et al. Effect of the R924Q von Willebrand factor substitution on the expression of the von Willebrand disease phenotype. Blood 2003; 102: Abstract 307.
38. Padgett RA, Grabowski PJ, Konarska MM, et al. Splicing of messenger RNA precursors. Annu Rev Biochem 1986; 55: 1119-50.
39. Bódo I, Katsumi A, Tuley EA, et al. Type 1 von Willebrand disease mutation Cys1149Arg causes intracellular retention and degradation of heterodimers: a possible general mechanism for dominant mutations of oligomeric proteins. Blood 2001; 98: 2973-9.
40. James PD, Notley C, Hegadorn C, et al. The mutational spectrum of type 1 von Willebrand disease: results from a Canadian cohort study. Blood first edition paper, prepublished online August 10, 2006; doi:10.1182/ blood-2006-05-021105.
41. Keightley AM, Lam YM, Brady JN, et al. Variation at the von Willebrand factor (vWF) gene locus is associated with plasma vWF:Ag levels: identification of three novel single nucleotide polymorphisms in the vWF gene promoter. Blood 1999; 93: 4277-83.
42. Johansson AM, Säll T, Lethagen S, et al. The haplotype structure of the von Willebrand factor (VWF) gene promoter indicates balancing selection. J Thromb Haemost 2005; 3 (Suppl 1): Abstract P1466.
43. Kunicki TJ, Federici AB, Salomon DR, et al. An association of candidate gene haplotypes and bleeding severity in von Willebrand disease (VWD) type 1 pedigrees. Blood 2004; 140: 2359-67.
44. 1 levels in type 1 von Willebrand disease correlate with impaired platelet function in a high shear stress system. Blood 1999; 93: 3578-82.